M
Monica M. Farley
Researcher at Veterans Health Administration
Publications - 28
Citations - 5516
Monica M. Farley is an academic researcher from Veterans Health Administration. The author has contributed to research in topics: Population & Incidence (epidemiology). The author has an hindex of 19, co-authored 28 publications receiving 5098 citations. Previous affiliations of Monica M. Farley include University of Georgia.
Papers
More filters
Journal ArticleDOI
Burden of Clostridium difficile Infection in the United States
Fernanda C. Lessa,Yi Mu,Wendy Bamberg,Zintars G. Beldavs,Ghinwa Dumyati,John R. Dunn,Monica M. Farley,Stacy Holzbauer,James I. Meek,Erin C Phipps,Lucy E. Wilson,Lisa G. Winston,Jessica Cohen,Brandi Limbago,Scott K. Fridkin,Dale N. Gerding,L. Clifford McDonald +16 more
TL;DR: In this article, the authors used regression models to calculate estimates of national incidence and total number of infections, first recurrences, and deaths within 30 days after the diagnosis of C. difficile infection.
Journal ArticleDOI
Cigarette Smoking and Invasive Pneumococcal Disease
J P Nuorti,Jay C. Butler,Monica M. Farley,Lee H. Harrison,Allison McGeer,Margarette S. Kolczak,Robert F. Breiman +6 more
TL;DR: In this paper, the authors conducted a population-based case-control study to assess the importance of cigarette smoking and other factors as risk factors for pneumococcal infections and found that approximately half of otherwise healthy adults with invasive pneumococcemia are cigarette smokers.
Journal ArticleDOI
Active bacterial core surveillance of the emerging infections program network.
Anne Schuchat,Hilger T,Elizabeth R. Zell,Monica M. Farley,Arthur Reingold,Lee H. Harrison,Lewis Lefkowitz,Richard Danila,Karen Stefonek,Nancy L. Barrett,D. Morse,Robert W. Pinner +11 more
TL;DR: In 1998, early-onset group B streptococcal disease had declined by 65% over the previous 6 years, and 25% of invasive pneumococcal infections in ABCs areas were not susceptible to penicillin, and 13.3% were not susceptibility to three classes of antibiotics.
Journal ArticleDOI
Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.
Matthew R. Moore,Robert E. Gertz,Robyn L. Woodbury,Genevieve A Barkocy-Gallagher,William Schaffner,Catherine Lexau,Kenneth A. Gershman,Arthur Reingold,Monica M. Farley,Lee H. Harrison,James L. Hadler,Nancy M. Bennett,Ann Thomas,Lesley McGee,Tamara Pilishvili,Angela B. Brueggemann,Cynthia G. Whitney,James H. Jorgensen,Bernard Beall +18 more
TL;DR: PCV7 ineffectiveness against serotype 19A, antibiotic resistance, clonal expansion and emergence, and capsular switching have contributed to the genetic diversity of 19A and to its emergence as the predominant invasive pneumococcal serotype in the United States.
Journal ArticleDOI
Changes in Incidence and Antifungal Drug Resistance in Candidemia: Results From Population-Based Laboratory Surveillance in Atlanta and Baltimore, 2008–2011
Angela A. Cleveland,Monica M. Farley,Lee H. Harrison,Betsy Stein,Rosemary Hollick,Shawn R. Lockhart,Shelley S. Magill,Gordana Derado,Benjamin J. Park,Tom Chiller +9 more
TL;DR: Signs of marked shifts in candidemia epidemiology over the past 2 decades are described, with adults aged ≥65 years replaced infants as the highest incidence group and adjusted incidence has declined significantly in infants.